Solomon Nwaka

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. pmc Traditional medicines as a mechanism for driving research innovation in Africa
    Ivan Addae-Mensah
    Department of Chemistry, University of Ghana, Legon, Ghana
    Malar J 10:S9. 2011
  2. doi request reprint The Concept Paper on the Helminth Drug Initiative. Onchocerciasis/lymphatic filariasis and schistosomiasis: opportunities and challenges for the discovery of new drugs/diagnostics
    Alan Hudson
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, 20 Avenue Appia 1211 Geneva 27, Switzerland 41 22 791 3767 41 22 791 4825
    Expert Opin Drug Discov 2:S3-7. 2007
  3. pmc Integrated dataset of screening hits against multiple neglected disease pathogens
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland
    PLoS Negl Trop Dis 5:e1412. 2011
  4. pmc Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent
    Solomon Nwaka
    African Network for Drugs and Diagnostics Innovation, United Nations Economic Commission for Africa, Addis Ababa, Ethiopia
    BMC Int Health Hum Rights 12:11. 2012
  5. pmc CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
    Ian C Boulton
    Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
    Malar J 9:202. 2010
  6. ncbi request reprint Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines
    Solomon Nwaka
    Medicines for Malaria Venture MMV, P O Box 1826, CH 1215 Geneva 15, Switzerland
    Trans R Soc Trop Med Hyg 99:S20-9. 2005
  7. ncbi request reprint Innovative lead discovery strategies for tropical diseases
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization Geneva, Switzerland
    Nat Rev Drug Discov 5:941-55. 2006
  8. ncbi request reprint Interview with solomon nwaka
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases, WHO, Avenue Appia 20, 1211 Geneva 27, Switzerland
    Future Med Chem 3:1339-44. 2011
  9. doi request reprint Schistosomes: challenges in compound screening
    Bernadette Ramirez
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, 20, Avenue Appia 1211 Geneva 27, Switzerland 41 22 791 1060 41 22 791 4825
    Expert Opin Drug Discov 2:S53-61. 2007
  10. pmc Advancing drug innovation for neglected diseases-criteria for lead progression
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, Geneva, Switzerland
    PLoS Negl Trop Dis 3:e440. 2009

Collaborators

Detail Information

Publications13

  1. pmc Traditional medicines as a mechanism for driving research innovation in Africa
    Ivan Addae-Mensah
    Department of Chemistry, University of Ghana, Legon, Ghana
    Malar J 10:S9. 2011
    ..This report highlights key recommendations that have emerged through expert forums convened by ANDI on the challenges, opportunities and prospects for investing in this important area of research...
  2. doi request reprint The Concept Paper on the Helminth Drug Initiative. Onchocerciasis/lymphatic filariasis and schistosomiasis: opportunities and challenges for the discovery of new drugs/diagnostics
    Alan Hudson
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, 20 Avenue Appia 1211 Geneva 27, Switzerland 41 22 791 3767 41 22 791 4825
    Expert Opin Drug Discov 2:S3-7. 2007
    ..Recommendations are made for future efforts to maximise the possibilities for success, including the formation of a 'worm initiative' to promote a more integrated approach...
  3. pmc Integrated dataset of screening hits against multiple neglected disease pathogens
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases, World Health Organization, Geneva, Switzerland
    PLoS Negl Trop Dis 5:e1412. 2011
    ..Our work suggests that the efficiency of early drug discovery for neglected diseases can be enhanced through a collaborative, multi-pathogen approach...
  4. pmc Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent
    Solomon Nwaka
    African Network for Drugs and Diagnostics Innovation, United Nations Economic Commission for Africa, Addis Ababa, Ethiopia
    BMC Int Health Hum Rights 12:11. 2012
    ....
  5. pmc CRIMALDDI: a co-ordinated, rational, and integrated effort to set logical priorities in anti-malarial drug discovery initiatives
    Ian C Boulton
    Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK
    Malar J 9:202. 2010
    ..It is hoped that the recommendations will help to guide the priorities of the European anti-malarial research as well as the wider global discovery agenda in the coming decade...
  6. ncbi request reprint Drug discovery and beyond: the role of public-private partnerships in improving access to new malaria medicines
    Solomon Nwaka
    Medicines for Malaria Venture MMV, P O Box 1826, CH 1215 Geneva 15, Switzerland
    Trans R Soc Trop Med Hyg 99:S20-9. 2005
    ..All stages require partnership, sustainable financing and the engagement of disease-endemic countries. The recent G8 report on Africa has lent support to mechanisms aimed at improving health and achieving the Millenium Development Goals...
  7. ncbi request reprint Innovative lead discovery strategies for tropical diseases
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization Geneva, Switzerland
    Nat Rev Drug Discov 5:941-55. 2006
    ..This strategy offers the promise of reducing the inherently high attrition rate of the early stages of discovery research, thereby increasing the chances of success and enhancing cost-effectiveness...
  8. ncbi request reprint Interview with solomon nwaka
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases, WHO, Avenue Appia 20, 1211 Geneva 27, Switzerland
    Future Med Chem 3:1339-44. 2011
    b>Solomon Nwaka was born in Nigeria and grew up seeing at first hand the impact of neglected diseases. His research efforts have taken him across the globe, in both the developed and developing world...
  9. doi request reprint Schistosomes: challenges in compound screening
    Bernadette Ramirez
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, 20, Avenue Appia 1211 Geneva 27, Switzerland 41 22 791 1060 41 22 791 4825
    Expert Opin Drug Discov 2:S53-61. 2007
    ..It also highlights the best practices for compound screening in the TDR-designated compound screening centres and details some of the challenges involved in in vitro and in vivo compound screening...
  10. pmc Advancing drug innovation for neglected diseases-criteria for lead progression
    Solomon Nwaka
    Special Programme for Research and Training in Tropical Diseases TDR, World Health Organization, Geneva, Switzerland
    PLoS Negl Trop Dis 3:e440. 2009
    ..A set of criteria designed to facilitate compound progression from screening hits to drug candidate selection is presented to guide ongoing efforts...
  11. ncbi request reprint Virtual drug discovery and development for neglected diseases through public-private partnerships
    Solomon Nwaka
    Medicines for Malaria Venture, Geneva, Switzerland
    Nat Rev Drug Discov 2:919-28. 2003
  12. ncbi request reprint Mission possible
    Andrew L Hopkins
    Pfizer Global Research and Development, Sandwich, UK
    Nature 449:166-9. 2007
  13. ncbi request reprint Antimalarial drug discovery: efficacy models for compound screening
    David A Fidock
    Department of Microbiology and Immunology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA
    Nat Rev Drug Discov 3:509-20. 2004